Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Yakult Honsha discloses ACAT inhibitors

March 25, 1997

New drug therapy for erectile dysfunction more effective than PGE1

March 24, 1997

Lilly to discontinue or alter rHb1.1 collaboration with Somatogen

March 21, 1997

FDA clears Skelid

March 21, 1997

Amylin and J&J broaden collaboration

March 20, 1997

Collaboration formed to identify chronic anemia treatment

March 20, 1997

Phase II trial of Leukine as adjuvant for advanced melanoma

March 20, 1997

Grelan characterizes candidate for diabetic complications

March 20, 1997

Novel antihyperlipidemic agent from Shionogi in phase II

March 20, 1997

Wyeth-Ayerst acquires commercialization rights to rhIL-11

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...